genomic health inc
(GHDX:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)

Executive Profile*

Background*

Ms. Kimberly J. Popovits, Kim has been the Chief Executive Officer and President of Genomic Health Inc. since January 2009 and February 2002 respectively. Ms. Popovits served as the Chief Operating Officer at Genomic Health Inc. from February 2002 to January 2009. She has over twenty years of Pharmaceutical and Biopharmaceutical experience. She served in various roles at Genentech, Inc., as Senior Vice President of Marketing and Sales from February 2001 to February 2002 ... and as Vice President of Sales from October 1994 to February 2001. During her 15 years at Genentech, she led the successful commercialization of 14 new therapies, including Herceptin®, the revolutionary targeted treatment that changed the way doctors treat a particularly aggressive form of breast cancer. While at Genentech, Ms. Popovits led the launch of its oncology business and was vital to the development of its cardiovascular, endocrine and respiratory markets. She has extensive experience in building new markets and has consistently achieved market leadership through the development of innovative strategies focused on patient needs. Ms. Popovits joined Genentech in 1987. Prior to enentech, She served as Division Manager of American Critical Care, a division of American Hospital Supply. She has extensive operational experience in the areas of managed care, reimbursement and organization development. She has been the Chairman at Genomic Health Inc. since March 1, 2012. She served as Vice Chairman of Nuvelo Inc. since April 2008. Ms. Popovits has been a Director of Genomic Health Inc. since March 2002. She serves as a Director of Northern California's Life Science Association. She serves as a Director of Baybio. She served as Lead Independent Director of Nuvelo Inc. since April 2008 and served as its Director since July 2005. Ms. Popovits served as Director of ARCA biopharma, Inc. She serves as the President of The Coalition for 21st Century Medicine. Her contributions to science and the biotechnology industry have been acknowledged by multiple organizations including, being named as the Woman of the Year in 2008 by the Women Health Care Executives and as one of the Most Influential Women in the Bay Area by The San Francisco Business Times from 2006 to 2011. Ms. Popovits received BA in Business from Michigan State University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GHDX:US	$37.10 USD	-0.11

COMPETITOR COMPENSATION